The long-term objectives of this project are to develop in vivo and in vitro models for cutaneous lupus and to use these models to study the biology of cutaneous lupus. The athymic BALB/c mouse with grafted human skin was chosen as a potential animal model for cutaneous lupus. It has already been demonstrated that IgG from the sera of patients with photosensitive cutaneous lupus, injected intravenously (IV) into the nude mouse, will specifically bind to the human skin graft. These sera injected were """"""""monospecific"""""""" for anti-SSA antibodies, autoantibodies strongly associated with photosensitive cutaneous lupus. In the proposed model for cutaneous lupus, the human skin graft on the nude mouse will be exposed to ultraviolet (UV) light in the UVB and UVA ranges. The mouse will be injected IV with serum from a patient with photosensitive cutaneous lupus, then injected IV with human monocytes and lymphocytes or subsets thereof. Tissue injury will be determined by gross and microscopic changes compatible with cutaneous lupus. After an animal model for cutaneous lupus is developed, the model will be analyzed in detail to determine which components of the model are important in the development of skin disease. To aid in determining if an antibody of a particular specificity is required, a monoclonal anti-SSA antibody will be used. To study the contributions of lymphocytes and monocytes, cellular infiltrates in the grafts will be examined with monoclonal antibodies to cell surface antigens. In addition, specific subsets of lymphocytes or monocytes will be injected. To study the effects of UV light, animals each with 4 human skin grafts will be given different doses of UV light to each graft, and effects of UV light on antigen, antibody, and cells will be measured. Complementary to the animal model, an in vitro model using human basal keratinocytes cultured in serum-free medium will be developed. In this system antibody-dependent cell-mediated cytotoxicity and complement-mediated cytotoxicity will be compared as mechanisms for damaging basal keratinocytes, and the effects of UV light will be further studied. The ultimate goal of this work is a clearer understanding of the pathophysiology of cutaneous lupus.

Project Start
1985-07-01
Project End
1990-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
4
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Watson, R M; Scheel, J N; Petri, M et al. (1992) Neonatal lupus erythematosus syndrome: analysis of C4 allotypes and C4 genes in 18 families. Medicine (Baltimore) 71:84-95
David-Bajar, K M; Bennion, S D; DeSpain, J D et al. (1992) Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus. J Invest Dermatol 99:251-7
Lee, L A (1990) Maternal autoantibodies and pregnancy--II: The neonatal lupus syndrome. Baillieres Clin Rheumatol 4:69-84
Bennion, S D; Ferris, C; Lieu, T S et al. (1990) IgG subclasses in the serum and skin in subacute cutaneous lupus erythematosus and neonatal lupus erythematosus. J Invest Dermatol 95:643-6
Harley, J B; Sestak, A L; Willis, L G et al. (1989) A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease. Arthritis Rheum 32:826-36
Lee, L A; Gaither, K K; Coulter, S N et al. (1989) Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice. J Clin Invest 83:1556-62
Lee, L A; Weston, W L (1988) Neonatal lupus erythematosus. Semin Dermatol 7:66-72
Jones, S K; Coulter, S; Harmon, C et al. (1988) Ro/SSA antigen in human epidermis. Br J Dermatol 118:363-7
Furukawa, F; Lyons, M B; Lee, L A et al. (1988) Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. Another possible mechanism for estradiol influence of lupus erythematosus. J Immunol 141:1480-8